On January 24, 2022, Hemanext announced that its innovative blood processing and storage system has been recognized by the Association for the Advancement of Blood & Biotherapies (“AABB”), a leading international association in transfusion medicine and biotherapies, for compliance with its industry-recognized quality and safety standards SCoPE Program. The Hemanext technology is the first system providing both blood processing and storage to receive this designation.
- Hemanext Announces Appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East, and Africa
- Impact of the Age of Blood
- Science Innovation Forum
- Hemanext Announces Partnership with Aplastic Anemia & MDS International Foundation
- Hemanext ONE Becomes First Blood Processing and Storage System to Receive Standards-Compliant Seal from AABB